
Pfizer ETFs to Rise on FDA's EUA for COVID-19 Oral Antiviral Pill
Published on December 23, 2021
Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the receipt of EUA for the antiviral COVID-19 pill.

Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the receipt of EUA for the antiviral COVID-19 pill.